Tips on Writing to the FDA

Do you have Nontuberculous
Mycobacterial (NTM) Pulmonary Disease?

The voice of the patient has a role in the drug development and approval process. In fact, recent legislation mandates an increased emphasis on incorporating the patient perspective into the drug approval process.

220,000

ESTIMATED CASES
OF NTM IN THE US
IN 2020

8.2 %

 THE RISE IN THE
NUMBER OF NTM CASES
EACH YEAR

2.8m

ANTIBIOTIC-
RESISTANT INFECTIONS
IN THE US EACH YEAR